Takahiro Matsumoto. Investigation and development of natural products that target chemotherapy resistance factors in cancer cells. J. Nat. Med , 2025, 79, 1005-1016.
Takahiro Matsumoto, Miho Hamai, Yayako Inui, Tomoe Ohta, Tatsusada Yoshida, Naoto Kojima, Hayato Yoshikawa, Raku Kutose, Shiori Ando, Tetsushi Watanabe. Chemical structures of polyketides and alkaloids isolated from a culture of fungus Curvularia moringae. Fitoterapia, 2024,179,106263.
Kousuke Araki, Minami Hara, Shohei Hamada, Takahiro Matsumoto, Seikou Nakamura. Antiproliferative Activities of Cynaropicrin and Related Compounds against Cancer Stem Cells. Chem. Pharm. Bull., 2024,72, 200-208.
Takahiro Kitagawa, Takahiro Matsumoto, Tomoe Ohta, Tatsusada Yoshida, Youhei Saito, Yuji Nakayama, Yuki Hadate, Eishi Ashihara, Tetsushi Watanabe. Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7 J. Nat. Med, 2024, 78, 370-381.
Takahiro Matsumoto, Erika Ohnishi, Masaya Okayama, Tomoe Ohta, Tatsusada Yoshida, Shiori Ando, Raku Kutose, Takahiro Kitagawa, Tetsushi Watanabe. Chemical structures and cell-death-inducing activities of metabolites produced by Penicillium maximae. Tetrahedron Lett., 2024, 134,154851-154851.
Masaya Okayama, Takahiro Matsumoto, Takahiro Kitagawa, Seikou Nakamura, Tomoe Ohta, Tatsusada Yoshida, Tetsushi Watanabe. Cytotoxic activities of alkaloid constituents from the climbing stems and rhizomes of Sinomenium acutum against cancer stem cells. J. Nat. Med, 2024, 78, 226-235.